Heritage Wealth Advisors’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
PAG
SAM
SS
DB
NA
Heritage Wealth Advisors's CODX Position: Q1 2026 in Review
Heritage Wealth Advisors reduced its Co-Diagnostics (CODX) stake by 5.6% in Q1 2026, selling an estimated $3 and leaving 17 shares worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #670.
Heritage Wealth Advisors first reported a position in CODX in Q1 2020 and has held it in 25 quarters since. The position peaked at $10.2K in Q2 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.
- Heritage Wealth Advisors held 17 shares of Co-Diagnostics worth $32 as of Q1 2026.
- Heritage Wealth Advisors sold 1 Co-Diagnostics share in Q1 2026, an estimated $3.
- Co-Diagnostics made up ﹤0.01% of Heritage Wealth Advisors's portfolio in Q1 2026, its #670 holding.
- Heritage Wealth Advisors first reported a position in Co-Diagnostics in Q1 2020 and has held it in 25 quarters since.
- Heritage Wealth Advisors's Co-Diagnostics position peaked at $10.2K in Q2 2020.
- 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.
Based on Heritage Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.